Marine Biotech Newsletter. Issue 1 by unknown
        
 
| 1 
 
CONTENT 
EDITORIAL……………………………………………………………………...….………... 1 
MEET ERA-MBT’S INTERNATIONAL ADVISORY GROUP (IAG)…….………...….  2 
LOOKING FOR RESEARCH FUNDING? ............................................................................2 
MEET US IN LISBON AND INFLUENCE THE FUTURE OF ERA-MBT……………... 3 
THE VOICE OF A STAKEHOLDER…………………………………………………….… 3 
TOPIC PAGE: MACROALGAE FOR THE FUTURE………………...……………….… 4 
ERA-MBT IN A GLANCE.……………………………………...…………...……………… 6 
 
 
  
The Marine Biotechnology ERA-NET  
(ERA-MBT) is a consortium of 19 national 
funding agencies seeking complementarities 
between national activities by pooling resources 
to undertake joint funding of transnational 
projects in the area of Marine Biotechnology.  
 
During the lifetime of the project the following 
activities will be carried out, supporting the 
European Bioeconomy:  
 
• Launching three thematic calls to 
generate joint European research and 
development activities. 
• Arranging a number of stakeholder 
events to promote dialogue between 
science, industry and policy and to 
identify requirements for successful 
developments within the area. 
• Performing outreach activities to seek 
complementarities and avoid overlap 
with other activities sharing common 
interest with ERA-MBT. 
• Establishing a Strategic Roadmap with 
the support of the International 
Advisory Group, an expert panel 
reflecting views and expertise from the 
scientific, policy and business sectors. 
• Developing a perspective on the future 
of marine biotechnology research and 
development and its likely impacts. 
• Providing information about marine 
biotechnology in an online and open 
access portal with a wiki function. 
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How to make industry profit on marine 
biotechnology 
 
The ambition of the Marine Biotechnology ERA-NET  (ERA-MBT) 
is to establish a lasting network of stakeholders within marine 
biotechnology. Such a network will not be successful if the research 
and innovation provided cannot be turned into profitable results that 
can add benefit to the society. So it is important to build a viable 
environment where there are strong connections between research, 
innovation and a productive industry. 
 
In an article last year, the CEO of BioBridge, Meredith Lloyd-
Evans, asked the question: Who’s investing in marine biotech? A 
range of good examples were given on specific business cases where 
profits have already been made, and the great untapped potential 
was highlighted. However, the main question raised by Lloyd-Evans 
remains unanswered. 
 
… continued on page 2 
ERA-MBT Consortium at the kick-of meeting in Lillehammer,  
Norway on 29-30 January 2014. 
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MEET ERA-MBT’S 
INTERNATIONAL  
ADVISORY GROUP (IAG) 
 
 
The IAG will serve as ERA-MBT’s “think-tank” 
group and as a reference point for all strategic 
initiatives undertaken by the ERA-MBT consortium. 
Providing strategic guidance and advice, the IAG will 
be involved in ERA-MBT over the life-time of the 
project. The diverse background and experience of the 
IAG members will be of great importance when 
providing input to activities such as developing the 
strategic roadmap, defining research priorities and 
reviewing ERA-MBT performance, in addition to 
broader issues associated with the implementation of 
ERA-MBT. 
  
If you want to learn more about our 11 IAG members, 
please read about them on the ERA-MBT website. 
 
 
LOOKING FOR  
RESEARCH FUNDING? 
 
 
• What? 1st ERA-MBT transnational call: “The 
development of biorefinery processes for 
marine bioresources” 
• When? Preproposal submission deadline 
December 10, 2014 
• Why? To stimulate joint European research 
and development activities in marine 
biotechnology 
• Who? Researchers from the academic and the 
industrial sector 
 
More information including the  
call text and guidelines for  
applicants is available on the 
ERA-MBT website.  
 
Dr Torger Børresen 
Danish Agency for Science, Technology and Innovation 
(DASTI), Denmark 
In a recently conducted open stakeholder consultation, carried out as 
one of the ERA-MBT activities, it became clear that most companies 
characterizing themselves as marine biotechnology companies were 
small enterprises. The bigger industries may have some products on 
their product portfolio that can be said to be categorised as being 
made by using marine biotechnology, but they do not consider 
themselves as marine biotechnology companies. This raises another 
question: Is there anything such as a marine biotech industry sector? 
 
In another survey conducted by DG MARE earlier this year a Blue 
Biotechnology sector was identified as part of a larger 
biotechnological industry sector, and it was concluded that the Blue 
Biotechnology sector needed higher visibility. 
 
In the Blue Growth strategy launched by the EU as part of the 
Horizon 2020 programme, Blue biotechnology is one out of five 
different focus areas. In this strategy several opportunities for new 
business development are described, and the following is envisioned 
for the future development: 
 
‘In the very short term, the sector is expected to emerge as a 
niche market focused on high-value products for the health, 
cosmetic and industrial biomaterials sectors. By 2020, it could 
grow as a medium-sized market, expanding towards the 
production of metabolites and primary compounds (lipids, 
sugars, polymers, proteins) as input for the food, feed and 
chemical industries. In a third stage, around 15 years from now 
and subject to technological breakthroughs, the blue 
biotechnology sector could become a provider of mass-market 
products, together with a range of high added-value specialised 
products’. 
 
This is a good indication of how the marine biotechnology sector 
may develop to be profitable in the future. It is further expected that 
technological breakthroughs that will occur in what we can call the 
‘toolbox’ for biotechnology can strengthen the development. It is 
however necessary that there is a return on the investment in 
research and innovation. The more good examples we can get and 
the more we make them visible, the better the opportunities are for 
creating a viable marine biotechnology sector. 
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MEET US IN LISBON 
AND INFLUENCE  
THE FUTURE OF  
ERA-MBT 
 
 
• What? 1
st
 ERA-MBT Stakeholder 
meeting:  
 
WAVES OF INNOVATION - 
Integrating National Efforts to Build the 
Future of Marine Biotechnology 
 
• When? 28th - 29th October 2014 
 
• Why? To influence the future of ERA-
MBT as it seeks to expand and reinforce 
the network of researchers, industry, 
policy makers and funding agencies to 
support the development of European 
marine biotechnology.  
 
• Who? Scientists, companies, policy 
makers/advisors and other key 
individuals involved in or interested in 
furthering European Marine 
Biotechnology research and 
development.  
 
Detailed information on the event is available at 
the ERA-MBT website. 
 
 
 
 
 
THE VOICE OF  
A STAKEHOLDER 
 
 
An important role of the ERA-MBT is to have dialogue with its 
stakeholders.  Dr. Torger Børresen of DASTI talked to Mr. Per 
Møller, who works for the development department at the 
municipality of Kalundborg ( a small town in West-Zealand, 
Denmark), and is at the same time the founder of an SME aiming at 
creating new business in the local community. 
 
Q: Why is marine biotechnology interesting for you and 
your local area? 
 
A: The municipality has a general interest in promoting ‘green 
technology’ linked to test- and demonstration activities to generate 
value from reuse or upcycling of residual streams coming from 
industry, agriculture and aquaculture. We have facilitated this 
approach and activities related to what we call the Kalundborg 
Symbiosis where one company’s waste becomes a resource of the 
other. We thus have a range of projects turning waste streams into 
valuable products. The municipality has a large production facility of 
the enzyme producer Novozymes and the insulin producer Novo 
Nordisk within its borders, and some of the projects are performed in 
collaboration with these companies. For a number of years and with 
good results we have made experiments on growing microalgae on 
process water from these companies and when combined with the 
reuse of excess heat from wastewater and CO2 from fermentation off-
gas, this makes a very interesting business case. 
 
Q: What are the products you get out of the microalgae 
cultivation? 
 
A: We have put a lot of focus on establishing an economically sound 
dewatering and harvesting technology concept, which we have 
developed in collaboration with industry and university partners. Now 
we are at a stage where we use some of the obtained algae for fish 
feed experiments in collaboration with a global fish feed company. 
Furthermore, we have projects where we are experimenting with new 
ways of opening the algal cells making it possible to gently extract 
more valuable components for a full range of applications. Residuals 
from this refining approach are considered for use within the biofuel 
production, and a successful test on biogas potential has been 
performed, however growing microalgae for biofuels is currently not 
our primary target. 
Dr Per Møller 
Kalundborg Municipality, Denmark 
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Q. Are you participating in European collaboration? 
 
A: Absolutely. Many of our projects are performed together with 
partners in other European countries. They are partly academic 
institutions and partly industries. In some cases we participate in 
project consortia where large industry players are also taking part. 
 
Q: What is your opinion on the newly established ERA 
NET on marine biotechnology? 
 
A: Honestly, I have not much knowledge about the technicalities on 
how an ERA-NET works, but I am very positive about having more 
European collaboration on marine biotechnology, and I will be very 
interested in participating in new projects within the area. When 
participating as a municipality it is however usually a big challenge 
to join in if the requirements for our co-funding/in-kinds are too 
high. We mainly have to rely on and join programs where we can 
use our infrastructure and test- and demonstration facilities as a 
valid in-kind contribution. 
 
Q: ERA-MBT is seeking complementarities between 
national activities and aims at pooling resources for joint 
funding of transnational projects with the objective of 
better coordination of research and innovation within 
marine biotechnology. Is there such a need? 
 
A: The presently available project funds seem to be quite scattered, 
and not all of them fit our targets. If a more strategic and 
coordinated approach focusing on marine biotechnology can be 
established, life would be easier. My personal interests are within 
multistream biorefining linked to areas like marine biotechnology 
and this is what I will pursue in the future. 
 
 
 
Photocredit: Per Møller, 
Kalundborg Kommune 
TOPIC PAGE: 
MACROALGAE  
FOR THE FUTURE 
 
 
Macroalgae are an important potential source of 
ingredients for food, feed, biochemicals and biofuels 
production. While seaweed has already been on the 
menus of Asians countries for quite a while and some 
species have been extensively farmed, this resource is 
under-exploited in Europe where seaweed consumption 
is still rather poor. 
 
Seaweed is well known for its high content of 
hydrocolloids (alginate, carrageenan, and agar) which 
present specific chemical and physical properties and 
have already been commercialized, being used by the 
food industry as a thickener or emulsifier in chocolate 
milk, yoghurt and beer. Other components produced in 
the algae biomass have also been defined as higher 
value molecules and deserve greater attention in future 
research. 
 
Due to the above mentioned attributes, an increasing 
demand of seaweed biomass on an international scale 
can be noticed, resulting also in the rising recent 
interests of European researchers to develop cultivation 
methods and investigate the potential of native 
seaweeds.  
 
Within this research field we would like to highlight a 
national and a European research project aimed at 
fostering the biotechnology applications within the 
seaweed field. As part of these research endeavors, we 
would like to highlight two projects, one national and 
one European, which both aim at fostering 
biotechnology applications within the seaweed field. 
They are interesting for ERA-MBT, especially when 
considering the whole value chain, as techniques for 
sourcing the right raw material are important for core 
marine biotechnology elements, i.e. the processing and 
refining of biomass, into a spectrum of products that 
can be marketed profitably.  
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TASTE:  
a look at the application side 
 
The main objective of the European funded FP7 project 
TASTE project was to develop flavour ingredients from 
edible seaweeds (Ascophyllum nodosum, Saccharina 
latissima, and Fucus vesiculosus) with the potential to 
replace sodium in food products. This can be done through 
two options, namely flavour enhancing properties or 
mineral content. One of the work packages of the 
project focused on the process development of building 
blocks (i.e. single substances and compounds or natural 
mixtures thereof) with the main focus on enzyme hydrolysis 
to unlock minerals, flavour-active and flavour enhancing 
compounds.  The salt-reducing potential of building blocks 
was evaluated sensorially. In addition, physical methods 
like milling and high pressure homogenisation as 
complementing tools prior to or after the enzyme hydrolysis 
were studied. In the project the Icelandic Biotech company 
Prokazyme tested the application of a range of enzymes on 
seaweed raw materials. The company will continue to 
develop enzymes for applications in the marine biotech 
industry. 
 
TASTE was co-ordinated by Matis and finished in 
September 2014. 
 
More information on the can be found on the TASTE 
website  and from the TASTE coordinator Rósa Jónsdóttir. 
 
 
Photocredit: Ifremer 
 
“IDEALG, 2011-2020” is a large integrated long-term research 
project supported and funded by the French government with more 
than a hundred participants from 12 research institutes, 5 private 
companies and a seaweed technical center. The main aim of 
IDEALG is to tackle main issues related to seaweed production such 
as aquaculture techniques, biomass valorization, environmental 
impacts and socio-economic developments. The project will help 
improve algal bioresources and seaweed domestication as well as 
boost seaweed biotechnologies by making the best of genomics and 
post-genomic research. Indeed, metagenomic approaches applied on 
seaweed biomass and closely associated micro-organisms will bring 
progress to seaweed crops and developing blue and white 
technologies. The final goal is to bring forward basic knowledge and 
specific tools which are necessary to develop the marine 
biotechnology sector in France, hoping on a long term to fuel the 
applied sector and position France as a leader in the domain.  
 
 
The AT~SEA project (2012-2015) is an EU funded research project 
with seven European companies (including six SMEs) and four 
research institutes that aims to develop advanced seaweed cultivation 
technologies using innovative textiles that allow large scale and high 
yield cultivation of seaweed in Europe. This 2D approach, which is 
operational at pilot sites in Norway, Scotland and Ireland, generates 
yields that are three to five times higher than rope based cultivation. 
The AT~SEA consortium has applied for a patent on the advanced 
cultivation substrates and is studying the founding of a commercial 
company. The latter would develop and exploit an 8 ha 
demonstration site in 2015. In its final year the project team wants to 
demonstrate large scale seaweed cultivation on 200 m2 cultivation 
substrates in order to demonstrate the technical and economic 
feasibility of open sea cultivation of seaweeds in Europe. In the near 
future seaweeds will be an important biomass source for all kinds of 
biotechnological products (food/feed additives and nutraceuticals, 
biochemicals (including pharmaceuticals and cosmetics), etc.). 
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Newsletter acknowledgements 
The newsletter has been brought to you by the ERA-MBT editorial team: Steinar Bergseth (RCN), Fien De Raedemaecker 
(VLIZ), Kim Turk (MIZS) and Torger Børresen (DASTI) with the input of ERA-MBT partners. 
 
ERA-MBT 
IN A GLANCE 
 
 
Project Coordinator 
Steinar Bergseth 
The Research Council of Norway (RCN) 
+47 22037323 
 
ERA-MBT Partners 
The ERA-MBT partners welcome you to ERA-MBT and invite you to 
become involved in the shaping of a common ERA in Marine 
Biotechnology. Contact the individual project partners using the 
partner information page at the project website. 
 
Stay connected  
Subscribe to the newsletter mailing list 
 
 
Contribute to 
The MarineBiotech wiki-pages which aggregate information on 
marine biotechnology to inform funding agencies, stakeholders and 
the interested public about developments, achievements and 
knowledge in this area.  
 
A LinkedIn communication forum to support exchanges between 
stakeholders and to highlight opportunities for interlinkage and 
collaboration. 
 
Comments? Suggestions?  
Please contact us at info@marinebiotech.eu. 
 
Upcoming events 
We are collecting information on all events related to the field of 
marine biotechnology.  
To stay up to date, please visit our upcoming events page. If you 
cannot find the event you are organising or attending and would like to 
have it featured in our events calendar, please contact us.  
 
 
